Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 71, No. 3-4, 2006   

Free Abstract     Article (Fulltext)     Article (PDF 613 KB)     

Case Report

A Novel Case of Bisphosphonate-Related Osteonecrosis of the Torus Palatinus in a Patient with Metastatic Breast Cancer
Matthew L. Goldmana, Neelima Denduluria, Arlene W. Bermana, Rebecca Sausvillea, Jean-Pierre Guadagninic, David E. Kleinerb, Jaime S. Brahimd, Sandra M. Swaina

aBreast Cancer Section, Medical Oncology Branch and
bLaboratory of Pathology, National Cancer Institute,
cDental Consult Service and
dOral and Maxillofacial Surgery, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Md., USA

Address of Corresponding Author

Oncology 2006;71:306-308 (DOI: 10.1159/000106451)


 goto top of page Key Words

  • Zoledronic acid
  • Bisphosphonate toxicity
  • Maxillary exostosis
  • Jaw osteonecrosis
  • Torus palatinus

 goto top of page Abstract

Bisphosphonates administered orally and intravenously are used for a variety of endocrine and oncologic indications. Long-term intravenous use of bisphosphonates has been shown to cause osteonecrosis of the jaw. We report a case in which a 58-year-old woman with metastatic breast cancer received 18 doses of 4 mg intravenous zoledronic acid over a period of 16 months and developed a region of osteonecrosis on the posterior edge of a large, lobular torus palatinus. Torus palatinus, a type of maxillary exostosis, is common among postmenopausal women, and is vulnerable to blunt trauma that could predispose to osteonecrosis. Sequestrum of dead bone was removed and the site healed within 4 weeks. This case demonstrates that patients with a torus palatinus may be at high risk for osteonecrosis, and reinforces the need for good oral hygiene and frequent dental examination while receiving bisphosphonate therapy.

Copyright © 2006 S. Karger AG, Basel


 goto top of page Author Contacts

Sandra M. Swain, MD
Breast Cancer Section, Medical Oncology Branch, Centre for Cancer Research
National Cancer Institute, National Institute of Health
8901 Wisconsin Ave, Building 8, Room 5101, Bethesda, MD 20889 (USA)
Tel. +1 301 435 5416, Fax +1 301 496 0047, E-Mail swains@mail.nih.gov


 goto top of page Article Information

Received: September 26, 2006
Accepted after revision: November 18, 2006
Published online: July 26, 2007
Number of Print Pages : 3
Number of Figures : 2, Number of Tables : 0, Number of References : 11

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 17657174)
Download Citation
Cited In

This journal is part of the fourth subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

Case Reports in Oncology


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2010 S. Karger AG, Basel